Recent studies indicate that popular weight-loss drugs, such as Ozempic and Wegovy, might play a role in treating or preventing certain cancers. This finding adds to the list of unexpected benefits linked to GLP-1s. Currently, one in eight American adults uses these medications.
William Brangham provides more details on this development. Brangham is a recognized correspondent and producer for PBS News Hour and also hosts Horizons from PBS.
Understanding and Addressing the Complexity of Suicide 
Recall of Meat Products from Star Meat Delivery Inc. 
Questions Arise After Presley Gerber’s Death in Rehab 
Upcoming Concerns and Influence in Health Politics 
Fraud Task Force Saves Billions by Tackling Obamacare Misuse 
Presley Gerber’s Passing Raises Addiction Recovery Concerns